Cargando…

Clinicopathologic significance of TROP2 and phospho-TROP2 in gastric cancer

Trophoblast cell-surface antigen 2 (TROP2) is a transmembrane glycoprotein expressed in epithelial cells. Increased TROP2 expression has been reported to be associated with malignant progression in most carcinomas; however, TROP2 has a tumor-suppressive function in certain types of cancer. Since the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kushiyama, Shuhei, Yashiro, Masakazu, Yamamoto, Yurie, Sera, Tomohiro, Sugimoto, Atsushi, Nishimura, Sadaaki, Togano, Shingo, Kuroda, Kenji, Yoshii, Mami, Tamura, Tatsuro, Toyokawa, Takahiro, Tanaka, Hiroaki, Muguruma, Kazuya, Nakada, Hiroshi, Ohira, Masaichi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2021
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8010512/ https://www.ncbi.nlm.nih.gov/pubmed/33815794 http://dx.doi.org/10.3892/mco.2021.2267

Ejemplares similares

Microscopic distance from tumor invasion front to serosa might be a useful predictive factor for peritoneal recurrence after curative resection of T3-gastric cancer
por: Togano, Shingo, et al.
Publicado: (2020)

Correction: Microscopic distance from tumor invasion front to serosa might be a useful predictive factor for peritoneal recurrence after curative resection of T3-gastric cancer
por: Togano, Shingo, et al.
Publicado: (2020)

The clinicopathologic significance of Tks5 expression of peritoneal mesothelial cells in gastric cancer patients
por: Sugimoto, Atsushi, et al.
Publicado: (2021)

The clinicopathological significance of Thrombospondin-4 expression in the tumor microenvironment of gastric cancer
por: Kuroda, Kenji, et al.
Publicado: (2019)

SDF1α/CXCR4 axis may be associated with the malignant progression of gastric cancer in the hypoxic tumor microenvironment
por: Yashiro, Masakazu, et al.
Publicado: (2021)

Circulating tumor cells with FGFR2 expression might be useful to identify patients with existing FGFR2‐overexpressing tumor
por: Kuroda, Kenji, et al.
Publicado: (2020)

Clinical difference between fibroblast growth factor receptor 2 subclass, type IIIb and type IIIc, in gastric cancer
por: Yashiro, Masakazu, et al.
Publicado: (2021)

Gastric cancer stem cells survive in stress environments via their autophagy system
por: Togano, Shingo, et al.
Publicado: (2021)

Lipocalin-2 negatively regulates epithelial–mesenchymal transition through matrix metalloprotease-2 downregulation in gastric cancer
por: Nishimura, Sadaaki, et al.
Publicado: (2022)

Establishment of a gastric cancer cell line with high microsatellite instability, OCUM‐13, derived from Borrmann type‐2 primary tumor
por: Yamamoto, Yurie, et al.
Publicado: (2022)

Significance of tumor heterogeneity of p-Smad2 and c-Met in HER2-positive gastric carcinoma with lymph node metastasis
por: Tsujio, Gen, et al.
Publicado: (2022)

Prognostic impact of postoperative systemic inflammatory response in patients with stage II/III gastric cancer
por: Kuroda, Kenji, et al.
Publicado: (2022)

CXCR2 signaling might have a tumor-suppressive role in patients with cholangiocarcinoma
por: Yamamoto, Yurie, et al.
Publicado: (2022)

Clinical significance of prognostic inflammation-based and/or nutritional markers in patients with stage III gastric cancer
por: Toyokawa, Takahiro, et al.
Publicado: (2020)

Preoperative C-reactive protein to albumin ratio predicts anastomotic leakage after esophagectomy for thoracic esophageal cancer: a single-center retrospective cohort study
por: Sugimoto, Atsushi, et al.
Publicado: (2021)

Clinical benefit for clinical sequencing using cancer panel testing
por: Nishimura, Sadaaki, et al.
Publicado: (2021)

The safe removal of a superior mediastinal foreign body by mediastinoscopy: a case report
por: Sakuma, Takashi, et al.
Publicado: (2022)

Clinical significance of coexisting histological diffuse type in stage II/III gastric cancer
por: Tanaka, Hiroaki, et al.
Publicado: (2021)

Neutrophils in primary gastric tumors are correlated with neutrophil infiltration in tumor-draining lymph nodes and the systemic inflammatory response
por: Hiramatsu, Soichiro, et al.
Publicado: (2018)

The pretreatment Controlling Nutritional Status (CONUT) score is an independent prognostic factor in patients with resectable thoracic esophageal squamous cell carcinoma: results from a retrospective study
por: Toyokawa, Takahiro, et al.
Publicado: (2016)

Comparison of the prognostic impact and combination of preoperative inflammation-based and/or nutritional markers in patients with stage II gastric cancer
por: Toyokawa, Takahiro, et al.
Publicado: (2018)

Trop petits pour Dieu /
por: Laederach, Monique, 1938-
Publicado: (1986)

Une trop bruyante solitude/
por: Hrabal, Bohumil, 1914-1997
Publicado: (1983)

Une fin trop précoce?
por: Rayson, Daniel
Publicado: (2022)

Clinical efficacy of nivolumab is associated with tertiary lymphoid structures in surgically resected primary tumors of recurrent gastric cancer
por: Mori, Takuya, et al.
Publicado: (2022)

Cervical chylous leakage following esophagectomy that was successfully treated by intranodal lipiodol lymphangiography: a case report
por: Tamura, Tatsuro, et al.
Publicado: (2017)

Association between the preoperative neutrophil-to-lymphocyte ratio and tertiary lymphoid structures surrounding tumor in gastric cancer
por: Yamakoshi, Yoshihito, et al.
Publicado: (2021)

C-reactive protein elevation ratio as an early predictor of postoperative severe complications after laparoscopic gastrectomy for gastric cancer: a retrospective study
por: Tanaka, Hiroaki, et al.
Publicado: (2019)

Trop-2 in Upper Tract Urothelial Carcinoma
por: Tomiyama, Eisuke, et al.
Publicado: (2022)

Uterine and ovarian carcinosarcomas overexpressing Trop-2 are sensitive to hRS7, a humanized anti-Trop-2 antibody
por: Raji, Rhoda, et al.
Publicado: (2011)

Epigenetically upregulating TROP2 and SLFN11 enhances therapeutic efficacy of TROP2 antibody drug conjugate sacitizumab govitecan
por: Zhao, Ming, et al.
Publicado: (2023)

Tertiary lymphoid structures show infiltration of effective tumor‐resident T cells in gastric cancer
por: Mori, Takuya, et al.
Publicado: (2021)

Clinical relevance of tertiary lymphoid structures in esophageal squamous cell carcinoma
por: Deguchi, Sota, et al.
Publicado: (2022)

Trop-2 protein as a therapeutic target: A focused review on Trop-2-based antibody-drug conjugates and their predictive biomarkers
por: Vranic, Semir, et al.
Publicado: (2022)

Trop-2 Is a Determinant of Breast Cancer Survival
por: Ambrogi, Federico, et al.
Publicado: (2014)

The Potential Diagnostic Utility of TROP-2 in Thyroid Neoplasms
por: Liu, Haiyan, et al.
Publicado: (2017)

Targeting Trop-2 in solid tumors: future prospects
por: Zaman, Saif, et al.
Publicado: (2019)

Contrôles anti-dopage : trop, pas assez, autrement ?
por: Kintz, Pascal
Publicado: (2020)

Trop2: Jack of All Trades, Master of None
por: Lenárt, Sára, et al.
Publicado: (2020)

TROP2 modulates the progression in papillary thyroid carcinoma
por: Sun, Huali, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_iehkk0c6tu56rrluqc5sc9gh8n